Executive Summary: AI-powered diagnostics companies are valued differently from traditional healthcare businesses because their economics are driven not only by current revenue, but also by FDA clearance, clinical validation, reimbursement readiness, and the durability of licensing relationships. For Houston business owners, investors, and advisors, understanding how diagnostics companies are priced is essential when preparing for […]
Executive Summary: Revenue cycle management (RCM) software businesses are valued on more than just reported revenue. Buyers and investors focus on the strength of recurring revenue, revenue per provider, claim success rates, net revenue retention (NRR), and the degree to which the platform is embedded in a customer’s day-to-day workflow. Because RCM systems sit at […]
Executive summary: Valuing a telehealth platform requires more than looking at headline revenue growth. Buyers and investors pay close attention to patient visit volume, revenue per visit, payer contract penetration, retention, and how the business performs as demand normalizes after the pandemic era. In practice, telehealth platforms are often valued using a blend of discounted […]
Digital health companies are valued differently from traditional service businesses because their worth is tied not only to current earnings, but also to recurring revenue quality, patient engagement, clinical credibility, and regulatory readiness. For Houston business owners, investors, and advisors, understanding how healthtech companies are priced is essential when preparing for a sale, raising capital, […]
Executive Summary: InsurTech valuations depend on more than topline growth. Buyers and investors look closely at loss ratio, combined ratio, premium growth, retention, and the quality of distribution to determine whether growth is durable and profitable. In a sector where technology can accelerate customer acquisition and underwriting efficiency, valuation still comes down to disciplined financial […]
Executive Summary: Buy-now-pay-later, or BNPL, was once valued primarily on growth, user adoption, and gross merchandise volume. That approach has changed. Today, investors and buyers are looking much more closely at the economics behind the volume, including GMV, merchant fee rate, default rate, contribution margin, funding costs, and the path to sustainable profitability. For BNPL […]
Executive Summary. Neobank valuation is very different from valuing a traditional bank. Instead of relying primarily on price-to-book multiples, investors typically focus on customer economics, deposit growth, revenue per account, customer acquisition cost, net revenue retention, churn, and the company’s path to sustainable profitability. For Houston business owners, accountants, and investors evaluating a digital bank […]
Payment processing companies are valued by the quality of their recurring economics, not just by revenue growth. The most important drivers are total payment volume (TPV), take rate, gross margin, and churn, because they reveal how much revenue the business can generate from each dollar of processed volume, how efficiently it converts that revenue into […]
Executive Summary: Fintech business valuation is not just about current revenue, it is about how durable that revenue is, how efficiently the company acquires and retains customers, and how much regulatory and operational risk sits behind the growth story. Investors typically value fintech companies, including payments, lending, and neobanking platforms, using a combination of revenue […]
Executive Summary: A 409A valuation determines the fair market value of a private company’s common stock for stock option pricing. For SaaS startups, this report is essential because it establishes the strike price for equity compensation, helps demonstrate IRS compliance, and reduces audit exposure for founders, boards, and investors. It is especially important when a […]
- 1
- 2